Technical Analysis for NAVB - Navidea Biopharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade D 0.901 -0.66% -0.01
NAVB closed down 0.66 percent on Friday, September 20, 2019, on 2.52 times normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Earnings due: Sep 27

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Up Up
See historical NAVB trend table...

Date Alert Name Type % Chg
Upper Bollinger Band Walk Strength 0.00%
Wide Bands Range Expansion 0.00%
Above Upper BB Strength 0.00%
Overbought Stochastic Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
Expansion Breakout Bullish Swing Setup -0.66%
Pocket Pivot Bullish Swing Setup -0.66%
Reversal New Highs Setup Bullish Swing Setup -0.66%
Wide Range Bar Range Expansion -0.66%
Upper Bollinger Band Walk Strength -0.66%

Older signals for NAVB ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision diagnostics and radiopharmaceutical agents. The company's radiopharmaceutical development programs include Lymphoseek Injection, a receptor-targeted small-molecule investigational radiopharmaceutical that is used in lymphatic mapping procedures, which are performed to help stage breast cancer and melanoma; and NAV4694, an F-18 radiolabeled positron emission tomography imaging agent, which is used as an aid in the diagnosis of patients with signs or symptoms of cognitive impairment, such as Alzheimer's disease. Its radiopharmaceutical development programs also comprise NAV5001, an Iodine-123 radiolabeled single photon emission computed tomography imaging agent that is used as an aid in the diagnosis of Parkinson's disease and other movement disorders with potential use as a diagnostic aid in dementia; and RIGScan, a radiolabeled monoclonal antibody that is developed as a diagnostic aid for use during surgery to help surgeons locate occult or metastatic cancer, primarily colorectal cancer. It has research and development agreements with University of California, AstraZeneca AB, Alseres Pharmaceuticals, Inc., and The Ohio State University. The company was formerly known as Neoprobe Corporation and changed its name to Navidea Biopharmaceuticals, Inc. in January 2012. Navidea Biopharmaceuticals, Inc. was founded in 1983 and is headquartered in Dublin, Ohio.
Medicine Biopharmaceutical Surgery Alzheimer's Disease Parkinson's Disease Medical Physics Melanoma Dementia Tomography Movement Disorders Metastasis Medicinal Radiochemistry Nuclear Medicine Radiopharmaceuticals Positron Emission Tomography University Of California Cognitive Impairment F 18 Positron Corporation Radiochemistry
Is NAVB a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 2 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 7.4
52 Week Low 0.49
Average Volume 119,381
200-Day Moving Average 1.9235
50-Day Moving Average 0.5988
20-Day Moving Average 0.641
10-Day Moving Average 0.7462
Average True Range 0.0687
ADX 30.73
+DI 35.572
-DI 6.9976
Chandelier Exit (Long, 3 ATRs ) 0.7539
Chandelier Exit (Short, 3 ATRs ) 0.7071
Upper Bollinger Band 0.8896
Lower Bollinger Band 0.3924
Percent B (%b) 1.02
BandWidth 77.566303
MACD Line 0.0726
MACD Signal Line 0.0372
MACD Histogram 0.0355
Fundamentals Value
Market Cap 145.96 Million
Num Shares 162 Million
EPS 0.48
Price-to-Earnings (P/E) Ratio 1.88
Price-to-Sales 3.31
Price-to-Book 4.17
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.02
Resistance 3 (R3) 1.03 0.99 1.00
Resistance 2 (R2) 0.99 0.96 0.99 0.99
Resistance 1 (R1) 0.95 0.94 0.93 0.94 0.99
Pivot Point 0.91 0.91 0.91 0.91 0.91
Support 1 (S1) 0.87 0.88 0.85 0.86 0.81
Support 2 (S2) 0.83 0.86 0.83 0.81
Support 3 (S3) 0.79 0.83 0.80
Support 4 (S4) 0.78